Evidence map›Paper›PMID 39171150›Full record

ArticleLeukemia research reports2024

Micro-transplantation in an elderly patient with very high risk MDS:A case report and literature review.

Kangli Wu, Mingsuo Liu, Yajun Wu, Qiulian Luo, Jin Chen, Wanling Xu, Xixi Yang, Piaoru Hong, Zhigang Qu

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia research reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kangli WuDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Mingsuo LiuDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Yajun WuDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Qiulian LuoDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Jin ChenDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Wanling XuDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Xixi YangDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Piaoru HongDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.
Zhigang QuDepartment of hematology, Yiwu Central Hospital, Yiwu, Zhejiang Province, 322099, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The prognosis of patients with myelodysplastic syndromes (MDS) (very high risk) is poor.HLA-mismatched allogeneic T-cell infusion which is called micro-transplantation can not only shorten the time of bone marrow suppression, but also improve the treatment response of patients. Case presentation: A 74-year-old woman presented with fatigue and showed pancytopenia on routine blood count. She was diagnosed with MDS (very high risk) after bone marrow examination,then she received 4 cycles of micro-transplantation. The progression-free survival was 22 months and overall survival was 33 months. Discussion: The patient showed good tolerance to micro-transplantation with manageable toxicities and short myelosuppression time.

Indexed as

Micro-transplantationMyelodysplastic syndromesMyelosuppressionTreatment

Identifiers

PMID39171150
PMCPMC11338110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.